US FDA accepts New Drug Application for GSK’s momelotinib for treatment of myelofibrosis
Regulatory submission included data from the pivotal Momentum phase-III clinical trial that met all primary and key secondary…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.